The Real Brokerage Inc. announced its financial results for the first quarter of 2026. Revenue during the quarter grew 32% year-over-year to $465.6 million. Gross profit grew 24% year-over-year to $42.2 million. Operating expenses also increased (17% year-over-year) to $45.6 million.

LifeVantage announced its financial results for the third fiscal quarter, ending March 31 2026. Gross profit during the quarter was $34.5 million, or 79% of revenue. This is a slight decrease from 81% of revenue in the same period of fiscal 2025, and is primarily due to an allowance for inventory obsolescence related to the MindBody GLP-1 System, as well as increased costs for shipping and warehousing. When adjusted for these considerations, gross profit was 79.4% of revenue.

USANA Health Sciences, Inc. announced its financial results for the first quarter of 2026. Net sales remained stable year-over-year at $250 million. Net earnings were $7.5 million, down from $9.4 million in the same quarter of 2025. Diluted EPS was $0.41 with an adjusted EBITDA of $28.4 million.

Natural Health Trends Corp. announced its financial results for the first quarter of 2026. Revenue during the period was $9.2 million, down 6% sequentially and 14% from the same period of 2025. Operating loss during the quarter was $474,000, compared to $635,000 in the previous quarter and $345,000 in the first quarter of last year.

Mannatech announced its financial results for the fourth quarter of 2025, as well as year-ending results. Net sales in the fourth quarter were $26.6 million, compared to $29 million in the fourth quarter of 2024.

Herbalife Ltd. announced its preliminary financial results for the first quarter of 2026. Net sales grew 7.5-8% year-over-year, which exceeded the high end of the company’s previously issued first quarter guidance. This net sales performance was driven by the Asia Pacific market, with Latin America and Mexico also reporting year-over-year net sales growth.

Zinzino AB reported its preliminary sales results for the first quarter of 2026. Group revenue in the first quarter reached $96.8 million, a 26% year-over-year increase, while the Faun Pharma external sales division fell from approximately $751,000 to approximately $698,000.

Amway announced its financial results for 2025. Sales in 2025 were $7.3 billion. The company stated that “while sales were modestly lower than the previous year, the company advanced key priorities across the business, with many markets and product launches outperforming forecasts and building positive traction heading into 2026.”

The company recorded a net income for the second consecutive quarter and experienced a positive adjusted EBITDA for the ninth consecutive quarter. The company generated positive free cash flow with $39 million in cash on its balance sheet and said it is now preparing for the next phase of its growth strategy.

Nature’s Sunshine announced its financial results for the fourth quarter and full-year 2025. Fourth quarter net sales were up 4.7% year-over-year to $123.8 million with an adjusted EBITDA of $11.9 million, a 16% increase from the same quarter of 2024.

LR Health & Beauty announced its financial results for the fourth quarter 2025 and preliminary sales and earnings results for full year 2025. Revenue during the quarter was $80.3 million, a 10.9% decline that the company attributed to subdued consumer sentiment in Western European markets.

Herbalife Ltd. announced its financial results for the fourth quarter and full year 2025. Net sales during the quarter were up 6.3% to $1.3 billion with an adjusted net income of $47.5 million and an adjusted EBITDA of $156.1 million. Diluted EPS during the quarter was $0.81.